Evaluation of whole exome sequencing by targeted gene sequencing and Sanger sequencing

Conclusions The results of NGS-based methods must currently be validated, especially for important reported variants regardless of the methods used, and for the use of WES in cancers a higher false negative rate must be considered. More sensitive methods should be used to confirm the NGS results in uneven cancer tissues. (Source: Clinica Chimica Acta)

from ! Medicine by Alexandros G. Sfakianakis via alwin on Inoreader http://ift.tt/2swDuTn
via IFTTT